This study aims to provide an understanding of the dynamics and forecasts of the OTC drugs, medical devices and diagnostic kits market worldwide and provides key market propositions over a five-year forecast period.
This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for OTC drugs, medical devices and diagnostic kits used for self-care and the management of various common diseases.
The report covers developed and emerging markets in order to help readers understand:
Detailed description, including demographics and cost burden, of various diseases including cardiovascular diseases, orthopedic diseases, respiratory disorders, diabetes, obesity, gastrointestinal disorders, sleep disorders, skin disorders, and ENT disorders.
Detailed description and analysis of current OTC drugs, medical devices and diagnostic kits.
Market characterization, unmet need, and market size and segmentation (by region, by segment, by diseases).
The current state of the market and the key markets for its future development.
Major regional trends.
Market drivers and restraints.
Detailed market projections through 2024.
Global competitive thrust in terms of competition and market shares.
Key marketed and pipeline (research and development) products along with information about their regulatory status.
Strategic landscape (mergers and acquisitions).
Regulatory structure: new regulations that will influence the development of the OTC drugs, devices and diagnostics market.
Pricing and reimbursement.
Observations and conclusions on the future of OTC drugs, medical devices and diagnostics.
Profiles of market participants and associations.
The Report Includes:
26 data tables and 22 additional tables
An overview of the global markets for over-the-counter (OTC) drugs, medical devices and diagnostics
Analyses of global market trends with data from 2018 and 2019, and projections of CAGRs through 2024
Coverage of various target diseases, including common health disorders and severe chronic diseases where OTC drugs and devices play a key role in the management of diseases
Assessment of the recent breakthroughs, current research activities, technological hurdles and latest trends related to the field of medical technologies
Complete understanding about the usage and adoption rate of OTC drugs, devices and diagnostic kits in various regions
Underlying details of key business opportunities to pivotal stakeholders to expand of business and capture the revenue in the specific verticals to analyze before investing or expanding the horizon within this market
Competitive landscape encompassing a large chunk of small, medium and large players on both pharmaceutical drugs and medical devices and diagnostics side
Profile description of leading market players, including 3M, Akron, Bayer AG, Celgene, and Eli Lilly and Co.
About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'. Add this page to your favorite Social Bookmarking websites